资讯|论坛|病例

搜索

首页 医学论坛 专业文章 医学进展 签约作者 病例中心 快问诊所 爱医培训 医学考试 在线题库 医学会议

您所在的位置:首页 > 血液科诊疗指南 > 2002CDC预防HIV感染病人机会性感染指南

2002CDC预防HIV感染病人机会性感染指南

2014-05-23 17:03 阅读: 来源:爱爱医 责任编辑:张子玲
[导读] In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelinesfor preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV).

    《2002CDC预防HIV感染病人机会性感染指南》内容简介:

    
In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelinesfor preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV); these guidelineswere updated in 1997 and 1999. This fourth edition of the guidelines, made available on the Internet in 2001, is intended forclinicians and other health-care providers who care for HIV-infected persons.

    《2002CDC预防HIV感染病人机会性感染指南》内容预览:

 
  In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelinesfor preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV); these guidelineswere updated in 1997 and 1999. This fourth edition of the guidelines, made available on the Internet in 2001, is intended forclinicians and other health-care providers who care for HIV-infected persons. The goal of these guidelines is to provide evidence-based guidelines for preventing OIs among HIV-infected adults and adolescents, including pregnant women, and HIV-exposed orinfected children. Nineteen OIs, or groups of OIs, are addressed, and recommendations are included for preventing exposure toopportunistic pathogens, preventing first episodes of disease by chemoprophylaxis or vaccination (primary prophylaxis), and pre-venting disease recurrence (secondary prophylaxis)。 Major changes since the last edition of the guidelines include 1) updatedrecommendations for discontinuing primary and secondary OI prophylaxis among persons whose CD4+T lymphocyte counts haveincreased in response to antiretroviral therapy; 2) emphasis on screening all HIV-infected persons for infection with hepatitis Cvirus; 3) new information regarding transmission of human herpesvirus 8 infection; 4) new information regarding drug interac-tions, chiefly related to rifamycins and antiretroviral drugs; and 5) revised recommendations for immunizing HIV-infected adultsand adolescents and HIV-exposed or infected children.

    点击下载完整版:http://ziyuan.iiyi.com/source/down/2343161.html


分享到:
  版权声明:

  本站所注明来源为"爱爱医"的文章,版权归作者与本站共同所有,非经授权不得转载。

  本站所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们

  联系zhoumeifang@120.net,我们将立即进行删除处理

意见反馈 关于我们 隐私保护 版权声明 友情链接 联系我们

Copyright 2002-2019 Iiyi.Com All Rights Reserved